Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities

Takeo Kasagami; In Hae Kim; Hsing Ju Tsai; Kosuke Nishi; Bruce D. Hammock; Christophe Morisseau

doi:10.1016/j.bmcl.2009.01.069

Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities

Takeo Kasagami, In Hae Kim, Hsing Ju Tsai, Kosuke Nishi, Bruce D. Hammock, Christophe Morisseau

Entomology

Research output: Contribution to journal › Article

22 Scopus citations

Abstract

We investigated N-adamantyl-N′-phenyl urea derivatives as simple sEH inhibitors. Salicylate ester derivatives have high inhibitory activities against human sEH, while the free benzoic acids are less active. The methyl salicylate derivative is a potent sEH inhibitor, which also has high metabolic and chemical stabilities; suggesting that such inhibitors are potential lead molecule for bioactive compounds acting in vivo.

Original language	English (US)
Pages (from-to)	1784-1789
Number of pages	6
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	19
Issue number	6
DOIs	https://doi.org/10.1016/j.bmcl.2009.01.069
State	Published - Mar 15 2009

Fingerprint

Keywords

Anti-inflammation
Hypertension
Intramolecular hydrogen bond
Metabolic and chemical stability
Salicylate
Soluble epoxide hydrolase
Urea

ASJC Scopus subject areas

Pharmaceutical Science
Drug Discovery
Organic Chemistry
Molecular Medicine
Molecular Biology
Clinical Biochemistry
Biochemistry

Cite this

Kasagami, T., Kim, I. H., Tsai, H. J., Nishi, K., Hammock, B. D., & Morisseau, C. (2009). Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorganic and Medicinal Chemistry Letters, 19(6), 1784-1789. https://doi.org/10.1016/j.bmcl.2009.01.069

@article{0298b64a77524554a6d1a1603ce14344,

title = "Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities",

abstract = "We investigated N-adamantyl-N′-phenyl urea derivatives as simple sEH inhibitors. Salicylate ester derivatives have high inhibitory activities against human sEH, while the free benzoic acids are less active. The methyl salicylate derivative is a potent sEH inhibitor, which also has high metabolic and chemical stabilities; suggesting that such inhibitors are potential lead molecule for bioactive compounds acting in vivo.",

keywords = "Anti-inflammation, Hypertension, Intramolecular hydrogen bond, Metabolic and chemical stability, Salicylate, Soluble epoxide hydrolase, Urea",

author = "Takeo Kasagami and Kim, {In Hae} and Tsai, {Hsing Ju} and Kosuke Nishi and Hammock, {Bruce D.} and Christophe Morisseau",

year = "2009",

month = mar

day = "15",

doi = "10.1016/j.bmcl.2009.01.069",

language = "English (US)",

volume = "19",

pages = "1784--1789",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "6",

}

TY - JOUR

T1 - Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities

AU - Kasagami, Takeo

AU - Kim, In Hae

AU - Tsai, Hsing Ju

AU - Nishi, Kosuke

AU - Hammock, Bruce D.

AU - Morisseau, Christophe

PY - 2009/3/15

Y1 - 2009/3/15

N2 - We investigated N-adamantyl-N′-phenyl urea derivatives as simple sEH inhibitors. Salicylate ester derivatives have high inhibitory activities against human sEH, while the free benzoic acids are less active. The methyl salicylate derivative is a potent sEH inhibitor, which also has high metabolic and chemical stabilities; suggesting that such inhibitors are potential lead molecule for bioactive compounds acting in vivo.

AB - We investigated N-adamantyl-N′-phenyl urea derivatives as simple sEH inhibitors. Salicylate ester derivatives have high inhibitory activities against human sEH, while the free benzoic acids are less active. The methyl salicylate derivative is a potent sEH inhibitor, which also has high metabolic and chemical stabilities; suggesting that such inhibitors are potential lead molecule for bioactive compounds acting in vivo.

KW - Anti-inflammation

KW - Hypertension

KW - Intramolecular hydrogen bond

KW - Metabolic and chemical stability

KW - Salicylate

KW - Soluble epoxide hydrolase

KW - Urea

UR - http://www.scopus.com/inward/record.url?scp=61349106718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349106718&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2009.01.069

DO - 10.1016/j.bmcl.2009.01.069

M3 - Article

C2 - 19216074

AN - SCOPUS:61349106718

VL - 19

SP - 1784

EP - 1789

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 6

ER -

Access to Document

10.1016/j.bmcl.2009.01.069